Hearing aids can make conversation easier to follow. Could they also help preserve thinking skills as people age? A large U.S. study called ACHIEVE put that possibility to a three-year test—and found an answer that is promising, but more limited than a simple “hearing aids prevent dementia” headline would suggest.
Across the trial as a whole, a hearing intervention did not significantly slow the average decline in cognitive test scores. But among participants who entered the study with a higher risk of cognitive decline, scores fell more slowly for those offered hearing care than for those who received health education. The researchers estimated that the intervention slowed cognitive decline by 48% in this subgroup.
That contrast is the key to understanding the result. It is evidence that addressing hearing loss may help protect cognitive health for some older adults—not proof that hearing aids prevent dementia, or that every person who wears them will gain a cognitive benefit.
What the ACHIEVE trial tested
The randomized trial enrolled 977 adults aged 70 to 84 who had untreated hearing loss and no substantial cognitive impairment at the start. Participants were assigned either to a hearing intervention or to a health-education control group. The hearing program included hearing aids and audiological support, such as counseling and follow-up. Researchers tracked participants for three years and assessed changes in cognition using a measure that combined results from several tests.
The study brought together two different groups. One consisted of older adults recruited from the community for the trial. The other came from the long-running Atherosclerosis Risk in Communities study, known as ARIC. Those ARIC participants tended to have more risk factors for cognitive decline and, as a group, showed faster decline during the study.
When researchers analyzed all participants together, the intervention did not significantly change the rate of cognitive decline. The more striking finding emerged when they looked separately at the ARIC group. In that higher-risk group, the hearing intervention was associated with a slower decline—an estimated 48% less decline over three years compared with the control group. The same clear benefit did not appear in the healthier group recruited specifically for ACHIEVE.
Why the overall result and subgroup result differ
A subgroup finding can be important without applying to everyone. In this case, the researchers had planned to examine the two groups separately, and the difference in their starting risk helps explain why the results might diverge. People who are already declining faster may have more opportunity for an intervention to make a measurable difference over a few years. But a result in one subgroup still needs careful interpretation and further study.
The trial also measured change on cognitive tests, not whether participants developed dementia. A slower decline on a test is not the same thing as preventing a diagnosis, and the study did not show that hearing care reverses existing cognitive problems. Its results describe an average difference between groups over a defined period—not a prediction for any one person.
Researchers have suggested several possible links between hearing and brain health. When sound is harder to understand, listening may demand more mental effort. Hearing difficulties can also make conversation and social participation less convenient. Improving access to sound could ease some of those challenges. But ACHIEVE was designed to test the effect of a hearing intervention, not to establish which biological or social pathway explains the subgroup result. Those explanations remain possibilities rather than proven mechanisms.
What the study means for people with hearing loss
The practical reason to seek help with hearing remains straightforward: hearing difficulty can interfere with conversations, safety, and daily life. If speech is often hard to follow—especially in groups or noisy places—a hearing evaluation can help identify the issue and discuss options. Hearing loss can have different causes, and an evaluation can also help determine whether a medical problem needs attention.
Hearing aids are not a universal, instant fix. They require appropriate fitting and may take time and support to use comfortably. The ACHIEVE intervention included professional care, not just handing participants a device, so its results should not be assumed to apply identically to every product or do-it-yourself approach.
For now, the trial supports a measured conclusion: treating hearing loss is worthwhile for hearing, and it may also help slow cognitive decline in some older adults at higher risk. It does not establish hearing aids as a stand-alone dementia-prevention strategy. Brain health depends on many influences, and this study tested one practical part of that picture. Larger follow-up research can help clarify who benefits most, how durable the effect is, and whether the slower test-score decline translates into meaningful differences in everyday life.
